“Free the vaccine!”

Podcast Episode Summary

The main topic of this episode of "Today Explained" is the Biden administration's decision to support waiving intellectual property protections for COVID-19 vaccines. This decision is a significant shift in U.S. policy and has been met with both praise and criticism from various stakeholders.

Key Points

• The Biden administration has announced its support for waiving intellectual property protections for COVID-19 vaccines, a move that could allow generic vaccines to be produced and distributed more widely.
• The decision is seen as a response to the growing demand for vaccine access in low-income countries, where vaccination rates are low and COVID-19 cases are surging.
• The pharmaceutical industry has opposed the waiver, arguing that it would undermine their intellectual property rights and slow down scientific innovation.
• Medical ethicist Harriet Washington argues that the Bayh-Dole Act of 1980, which allowed universities to patent and license their research, has led to a pharmaceutical industry culture driven by profit rather than medical need.
• Washington also notes that the patenting of drugs has enabled Western companies to charge high prices for life-saving medications, making them inaccessible to people in low-income countries.

Participants